Brand Information

CEFICAD INJ

Brand:
CEFICAD INJ

Manufacturer:
CADILA PHARMA

Compositions:
Cefepime hcl 500mg/1g injection,

Strength	Rate	Packing Style
500mg	184.25	1 injection
1g	344.00	1 injection

List of Related Indications:

Gynaecological infections
Intra-abdominal infection
Pneumonia
Septicaemia
Skin infection
Urinary tract infections- UTI

List Of Drugs:

Cefepime hcl - Cephalosporins @ - Third generation- (FDC-List)(Oct 2002)

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

Indication:

Approved by FDA on January 18, 1996

U.S FDA APPROVED DRUGS APPROVED FROM 01-01-08 TO 31-12-08

Drug name Indication Date of Approval

20. Cefepime (as hydrochloride) 2000/1000/500mg 24-01-08

+ Sulbactam (as sodium) 1000/500/250mg

per vial of injection

For serious CRTI,uncomplicated and complicated skin &

structure, infection acute exacerbation of chronic bronchtis

& intraabdominal infection

U.S. FDA APPROVED DRUGS DURING 2006

103. Cefepem (as HCL) 0.5/1gm 11-08-2006

+Amikacin (as sulphate) 0.125/0.250gm inj

antibiotic

133. Cefipime (as HCL) 500mg/1000mg 30-08-2006

+Tazobactum (as sodium) 62.5mg/125mg

per vial injection Antibiotic U.S.FDA APPROVED DRUGS DURING 2007

88. Cefepime injection 500mg/1gm/2gm 14-06-07

(For addtl.indication)

For bacterial meningitis in children

94. Cefepime Injection 14-06-07

(New indication)

For bacterial meningitis in children

118. Cefepime (250mg) 30-07-07

+Tazobactum 931.25mg) injection

(Addl.stgth)

As approved

Urinary tract infections

Drugs covered:

1st generation 2nd generation 3rd generation .

Cephalexin Cefaclor Cefixime Cefadroxil Cefamandole Cefoperazone Cephadrine Cefotoxitin Cefotaxime Cephalothin Cefuroxime Ceftizoxime Cephapirin Cefonicid Ceftriaxone Cefazolin Cefmetazole Ceftazidime Cefotetan Ceftibuten Cefprozil Cefepime Cefpodoxime Loracarbef

Refer Cephalosporins

Approved by (DCI) Drug Controller GENERAL - India For Marketing

(Ref- IDMA Publication)

Name of Drug Indication Date of Approval

1. Cefepime as Hcl 0.5/1gm + Amikacin 11-06-2006

as sulphate 0.125/0.250gm inj

Antibiotic

2. Cefepime 250mg + Tazobactum 30-07-2007

31.25mg injection ( Addl.strength)

Same as approved

3.Cefepime as HCl 500mg/1000mg + 30-08-2006

Tazobactum as sodium 62.5mg/125mg

Antibiotic

4. Cefepime as Hcl 2000/1000/500mg + 24-01-2008

Sulbactum as sodium 1000/500/250mg

per vial of injection

For serious CRTI.uncomplicated and complicated UTI,

uncomplicated skin & skin structure exacerbation of

chronic bronchitis & and intra-abdominal infection

5. Cefipime injection 500mg/1gm/2gm 14-06-2007

For bacterial menigintis in children

(Addl.indication)

6. Cefipime Hcl 30-10-2002

Antibiotic

FIXED DOSE COMBINATIONS APPROVED BY DCG(I)

FROM JANUARY 1961 TILL NOVEMBER 2014

Name of Drug Indication Date of Approval

1.Cefepime Hcl 0.5/1gm+ 08-11-2006

Amikacin sulphate 0.125/0.25gm injection

Antibiotic

2.Cefepime 250mg+ 30-07-2007

Tazobactam 31.25mg injection

Addl.Stgth

For the treatment of uncomplicated and compilacated UTI, uncomplicated

skin structure infections and complicated intra-abdominal infections

Addl.Indication-

LRTI including pneumonia & Bronchitis , septicaemia, empirc treatment in

febrile neurotropenic patients

3.Cefepime Hcl 500mg/1000mg+ 30-08-2006

Tazobactum as Sodium 62.5mg/125mg per injection

For the treatment of uncomplicated and compilacated UTI, uncomplicated

skin structure infections and complicated intra-abdominal infections

Addl.Indication-

LRTI including pneumonia & Bronchitis , septicaemia, empiric treatment in

febrile neurotropenic patients

4.Cefepime Hcl 2000/1000/500mg + 24-01-2008

Subactum as Sodium 1000/500/250mg per vial injection

For seroius CRTI ,uncomplicated and complicated UTI, uncomplicated

skin and skin structure , infection acute exacerbation of chronic

bronchitis & intraabdominal infection

Quick Links

Free Mobile App

About Us

FAQs

Feedback

Disclaimer: Every effort has been made to ensure that the information provided in this Database is authentic and accurate. Commissions or omissions in the database, if any, are purely inadvertent and the site owner shall not accept any liability whatsoever for any adverse consequences of any nature arising to any individual or third party, as a result of usage of this information.

CEFICAD INJ

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

Drug Interaction:

Indication:

Adverse Reaction:

Contra-Indications:

Dosages/ Overdosage Etc:

Patient Information:

Pharmacology/ Pharmacokinetics:

Pregnancy and lactation:

Search

Quick Links

Free Mobile App

	Starts With		Contains